The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

At its annual sellers’ conference, hosted in Seattle this week, Amazon continually told the thousands of independent vendors ...

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

Health-care company stocks fell as U.S. regulators look to crack down on prices and companies battle over market share of popular drugs. The Federal Trade Commission sued the drug middlemen that ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

Recently, the idea of reviving government price controls on food and other consumer staples has been injected into the public ...

The United States Eighth Circuit Court of Appeals ruled that legal challenges to the Horseracing Integrity and Safety Act ...

In the second quarter, federal and state antitrust enforcers continued their intense scrutiny of consolidation in the healthcare market ...

Two men are set to appear in federal court Friday after being arrested on charges of stealing and laundering $230 million in ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...